PrasadDevarajanMD
Pediatric Nephrology • Cincinnati, OHPediatric Kidney Stone Nephrology
Professor, Pediatrics, University of Cincinnati College of Medicine
Dr. Devarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
Ml 7022
Cincinnati, OH 45229Phone+1 513-636-4531Fax+1 513-636-7407
Summary
- Dr. Prasad Devarajan is a pediatric nephrologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. He received his medical degree from L. Tilak Municipal Medical College and has been in practice 34 years. He specializes in pediatric kidney stone nephrology. He has more than 350 publications and over 2000 citings.
Education & Training
Yale-New Haven Medical CenterFellowship, Pediatric Nephrology, 1991 - 1993
Stony Brook Medicine/University HospitalResidency, Pediatrics, 1986 - 1989
L. Tilak Municipal Medical CollegeClass of 1983
Certifications & Licensure
KY State Medical License 2021 - 2025
OH State Medical License 2003 - 2025
IN State Medical License 2021 - 2021
CT State Medical License 1993 - 1999- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Prospective Research Rare Kidney Stones (ProRKS) Start of enrollment: 2016 May 01
Roles: Contact
Publications & Presentations
PubMed
- Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts.Valeria Rudman-Melnick, Davy Vanhoutte, Kaitlynn Stowers, Michelle Sargent, Mike Adam
Scientific Reports. 2024-11-26 - Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts.Valeria Rudman-Melnick, Davy Vanhoutte, Kaitlynn Stowers, Michelle Sargent, Mike Adam
Research Square. 2024-08-17 - Plasma renin as a novel prognostic biomarker of sepsis-associated acute respiratory distress syndrome.Anjali Chakradhar, Rebecca M Baron, Mayra Pinilla Vera, Prasad Devarajan, Lakhmir Chawla
Scientific Reports. 2024-03-20
Journal Articles
- Discovery of SERPINA3 as a Candidate Urinary Biomarker of Lupus Nephritis ActivityMichael Bennett, Hermine I Brunner, Prasad Devarajan, Gaurav Gulati, Jessica L Turnier, Sherry Thornton, David Witte, Bruce Aronow, Rheumatology
Abstracts/Posters
- Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal StudyPrasad Devarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Section on Cardiology and Cardiac Surgery Program: Day 2National Conference & Exhibition 2019 - American Academy of Pediatrics - New Orleans, LA - 10/26/2019
Other
- Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosisDevarajan P
http://www.uptodate.com/contents/acute-kidney-injury-in-children-clinical-features-etiology-evaluati
UpToDate, Wolters Kluwer Health - 2013-04-01 - Prevention and management of acute kidney injury (acute renal failure) in childrenDevarajan P
http://www.uptodate.com/contents/prevention-and-management-of-acute-kidney-injury-acute-renal-failur
UpToDate, Wolters Kluwer Health - 2012-05-24
Press Mentions
BioPorto Is Proud to Have Nine of the Top-Ten Best US Children’s Hospitals as Customers of NGALOctober 22nd, 2024
Preliminary Data Suggests Potential Use Beyond Early AKI Diagnosis for NGAL BiomarkerJuly 17th, 2024- BioPorto Appoints World Leading Expert and Pioneer on the Clinical Utility of the NGAL Biomarker, Dr. Prasad Devarajan, MD FAAP FASN, as New Senior Medical DirectorJune 20th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
